Table 2 The risk factors leading to CIMT abnormality in T2DM patients
Variables | OR (95% CI) | p |
|---|---|---|
Gender | 39.95 (0.14–11,145.7) | 0.199 |
Age, years | 0.90 (0.74–1.09) | 0.274 |
BMI, kg/m2 | 2.69 (0.99–7.32) | 0.052 |
Illness years | 1.17 (0.88–1.54) | 0.278 |
Hypertension | 22.70 (0.35–1468.49) | 0.142 |
Cerebral infarction | 0.32 (4.86e−15–2.13e+13) | 0.944 |
Smoker | 133,860.6 (2.83–6.33e+09) | 0.032 |
Daily smoking amount | 0.75 (0.55–1.01) | 0.055 |
HDL, mmol/L | 0.01 (2.83e−07–467.55) | 0.410 |
LDL, mmol/L | 0.02 (0.0002–1.34) | 0.068 |
Total cholesterol, mmol/L | 22.06 (0.33–1497.07) | 0.151 |
Triglycerides, mmol/L | 0.75 (0.14–4.20) | 0.747 |
Creatinine, μmol/L | 1.00 (0.99–1.00) | 0.913 |
Serum urea, mmol/L | 2.71 (0.74–9.97) | 0.134 |
UA, μmol/L | 0.95 (0.91–0.99) | 0.047 |
C-peptide level | 0.06 (0.0005–5.58) | 0.220 |
0.5 h C-peptide level | 0.28 (0.01–6.45) | 0.429 |
2 h C-peptide level | 2.65 (1.00–7.00) | 0.049 |
Hba1c | 0.53 (0.17–1.63) | 0.267 |
FPG | 1.42 (0.73–2.77) | 0.305 |
PPG | 1.14 (0.77–1.67) | 0.518 |
HCY, mmol/L | 1.33 (0.80–2.21) | 0.279 |
MA/CR | 1.00 (0.99–1.00) | 0.093 |
PPGE | 0.59 (0.31–1.12) | 0.105 |
LAGE | 0.24 (0.05–1.20) | 0.081 |
SDBG | 281.99 (1.24–64,149.02) | 0.042 |